These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21826023)

  • 21. Mineralocorticoid receptor activation in obesity hypertension.
    Nagase M; Fujita T
    Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune system alterations by aldosterone during hypertension: from clinical observations to genomic and non-genomic mechanisms leading to vascular damage.
    Muñoz-Durango N; Barake MF; Letelier NA; Campino C; Fardella CE; Kalergis AM
    Curr Mol Med; 2013 Jul; 13(6):1035-46. PubMed ID: 23590758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of disease: The role of aldosterone in kidney damage and clinical benefits of its blockade.
    Del Vecchio L; Procaccio M; Viganò S; Cusi D
    Nat Clin Pract Nephrol; 2007 Jan; 3(1):42-9. PubMed ID: 17183261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-talk between aldosterone and angiotensin signaling in vascular smooth muscle cells.
    Rautureau Y; Paradis P; Schiffrin EL
    Steroids; 2011 Aug; 76(9):834-9. PubMed ID: 21371487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone.
    Weber KT
    J Lab Clin Med; 2003 Aug; 142(2):71-82. PubMed ID: 12960953
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fc-receptors as regulators of immunity.
    Nimmerjahn F; Ravetch JV
    Adv Immunol; 2007; 96():179-204. PubMed ID: 17981207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neurohormones and heart failure: the importance of aldosterone.
    Odedra K; Ferro A
    Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment.
    Sechi LA; Colussi G; Di Fabio A; Catena C
    Am J Hypertens; 2010 Dec; 23(12):1253-60. PubMed ID: 20706195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation.
    Zia AA; Kamalov G; Newman KP; McGee JE; Bhattacharya SK; Ahokas RA; Sun Y; Gerling IC; Weber KT
    Hypertens Res; 2010 Nov; 33(11):1091-101. PubMed ID: 20827279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular benefits of aldosterone receptor antagonists.
    Williams GH
    Climacteric; 2003 Oct; 6 Suppl 3():29-35. PubMed ID: 15018246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mineralocorticoids and cardiovascular diseases. Status of knowledge from experimental and clinical studies.
    Pasquale PD; Stefano GD; Paterna S
    Ital Heart J; 2000 Sep; 1(9):595-604. PubMed ID: 11130838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulatory T cells in health and disease.
    Piccirillo CA
    Cytokine; 2008 Sep; 43(3):395-401. PubMed ID: 18722786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Responses Triggered by the Immune System in Hypertensive Conditions and Repercussions on Target Organ Damage: A Review.
    da Silva CHND; Guedes IHL; de Lima JCS; Sobrinho JMDR; Dos Santos AA
    Curr Cardiol Rev; 2023; 19(2):e200922208959. PubMed ID: 36125837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salt, Aldosterone, and Parathyroid Hormone: What Is the Relevance for Organ Damage?
    Catena C; Colussi GL; Brosolo G; Bertin N; Novello M; Palomba A; Sechi LA
    Int J Endocrinol; 2017; 2017():4397028. PubMed ID: 29056965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New frontiers in aldosterone/mineralocorticoid biology: a reemerging force in target organ damage and hypertension.
    Kurtz TW; Catanzaro DF
    Am J Hypertens; 2001 Dec; 14(12):1276-7. PubMed ID: 11775139
    [No Abstract]   [Full Text] [Related]  

  • 37. The immunology of hypertension.
    Norlander AE; Madhur MS; Harrison DG
    J Exp Med; 2018 Jan; 215(1):21-33. PubMed ID: 29247045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone action: new answers, new questions.
    Funder JW
    Mol Cell Endocrinol; 1999 May; 151(1-2):1-3. PubMed ID: 10411314
    [No Abstract]   [Full Text] [Related]  

  • 39. Hormonal control of trained immunity: aldosterone at the crossroad between activation of innate immunity and cardiovascular diseases.
    Matarese G; Norata GD
    Cardiovasc Res; 2020 Feb; 116(2):256-257. PubMed ID: 31346597
    [No Abstract]   [Full Text] [Related]  

  • 40. Teleological coherence: exploring the dimensions of the immune system.
    Booth RJ; Ashbridge KR
    Scand J Immunol; 1992 Dec; 36(6):751-9. PubMed ID: 1462116
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.